Cementos Bio Bio S.A. (SNSE: CEMENTOS)
Chile
· Delayed Price · Currency is CLP 1,601.00
0.00 (0.00%)
Dec 20, 2024, 4:00 PM CLT
Cementos Bio Bio Cash Flow Statement
Financials in millions CLP. Fiscal year is January - December.
Millions CLP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 32,901 | 22,797 | 10,560 | 26,879 | 13,763 | 13,104 | Upgrade
|
| Depreciation & Amortization | 27,928 | 26,869 | 26,581 | 23,439 | 14,401 | 13,839 | Upgrade
|
| Other Amortization | 266.13 | 193.93 | 183.58 | 161.43 | 143.05 | 275.4 | Upgrade
|
| Asset Writedown & Restructuring Costs | 584.07 | 584.07 | 2,550 | 991.27 | 3,504 | 3,404 | Upgrade
|
| Other Operating Activities | -11,048 | -9,009 | -16,691 | -25,634 | 1,754 | -394.36 | Upgrade
|
| Operating Cash Flow | 50,631 | 41,435 | 23,183 | 25,836 | 33,565 | 30,228 | Upgrade
|
| Operating Cash Flow Growth | 40.08% | 78.73% | -10.27% | -23.03% | 11.04% | -21.00% | Upgrade
|
| Capital Expenditures | -16,786 | -18,144 | -13,808 | -21,976 | -9,339 | -12,447 | Upgrade
|
| Sale of Property, Plant & Equipment | 1,402 | 917.43 | 361.43 | 27,337 | 658.63 | 1,587 | Upgrade
|
| Divestitures | - | - | 80 | - | 79.81 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -193.38 | -182.8 | -516.55 | -78.51 | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | - | -2,581 | Upgrade
|
| Investing Cash Flow | -15,577 | -17,410 | -13,883 | 5,282 | -8,600 | -13,441 | Upgrade
|
| Short-Term Debt Issued | - | 6,976 | 18,809 | 4,853 | 20,000 | 854.58 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 10,000 | - | Upgrade
|
| Total Debt Issued | 10,139 | 6,976 | 18,809 | 4,853 | 30,000 | 854.58 | Upgrade
|
| Long-Term Debt Repaid | - | -21,465 | -33,280 | -13,259 | -32,982 | -24,161 | Upgrade
|
| Net Debt Issued (Repaid) | -15,596 | -14,489 | -14,471 | -8,405 | -2,982 | -23,306 | Upgrade
|
| Common Dividends Paid | -9,497 | -6,640 | -24,974 | -22,110 | -2,786 | -8,294 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | 157.2 | Upgrade
|
| Financing Cash Flow | -25,094 | -21,129 | -39,445 | -30,515 | -5,768 | -31,444 | Upgrade
|
| Foreign Exchange Rate Adjustments | -342.89 | 49.01 | -363.34 | 62.5 | -16.59 | 420.23 | Upgrade
|
| Net Cash Flow | 9,618 | 2,946 | -30,509 | 665.62 | 19,180 | -14,237 | Upgrade
|
| Free Cash Flow | 33,846 | 23,291 | 9,374 | 3,860 | 24,226 | 17,780 | Upgrade
|
| Free Cash Flow Growth | 91.84% | 148.45% | 142.83% | -84.06% | 36.25% | -19.25% | Upgrade
|
| Free Cash Flow Margin | 9.39% | 6.67% | 2.81% | 1.33% | 9.99% | 6.62% | Upgrade
|
| Free Cash Flow Per Share | 128.10 | 88.15 | 35.48 | 14.61 | 91.69 | 67.29 | Upgrade
|
| Cash Interest Paid | 13,687 | 14,925 | 8,193 | 3,677 | 4,655 | 5,360 | Upgrade
|
| Cash Income Tax Paid | - | -8,038 | 1,146 | 4,874 | 2,683 | 2,866 | Upgrade
|
| Levered Free Cash Flow | 22,608 | 15,534 | 8,739 | -9,254 | 27,121 | 10,447 | Upgrade
|
| Unlevered Free Cash Flow | 30,392 | 24,505 | 15,702 | -7,028 | 29,645 | 14,175 | Upgrade
|
| Change in Net Working Capital | 7,476 | 6,035 | 3,872 | 19,252 | -10,025 | -35.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.